AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01646463 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CenteringPregnancy
Description: CenteringPregnancy (CP) follows a standardized curriculum for group-based prenatal healthcare offered to groups of 10-12 women with similar due dates. In lieu of receiving a series of individually-delivered prenatal healthcare, participants meet 10 times over the course of pregnancy and early postpartum for 2 hour sessions, essentially pooling their minutes for each prenatal healthcare visit. The visit schedule adheres to the guidelines set forth by ACOG of monthly and then weekly visits close to birth. All sessions of CP include three core components of: (1) physical assessment (including blood pressure, weight, and fundal height assessment), (2) education and skills-building, and (3) support. Content topics for group discussion include nutrition, exercise, relaxation, understanding pregnancy problems, infant care and feeding, postpartum issues including contraception, comfort measures in pregnancy, sexuality and childbearing, abuse issues, parenting, and childbirth preparation.
Study NCT01646463 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CenteringPregnancy
Description: CenteringPregnancy (CP) follows a standardized curriculum for group-based prenatal healthcare offered to groups of 10-12 women with similar due dates. In lieu of receiving a series of individually-delivered prenatal healthcare, participants meet 10 times over the course of pregnancy and early postpartum for 2 hour sessions, essentially pooling their minutes for each prenatal healthcare visit. The visit schedule adheres to the guidelines set forth by ACOG of monthly and then weekly visits close to birth. All sessions of CP include three core components of: (1) physical assessment (including blood pressure, weight, and fundal height assessment), (2) education and skills-building, and (3) support. Content topics for group discussion include nutrition, exercise, relaxation, understanding pregnancy problems, infant care and feeding, postpartum issues including contraception, comfort measures in pregnancy, sexuality and childbearing, abuse issues, parenting, and childbirth preparation.
Study NCT01646463 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CenteringPregnancy with Mindfulness Skills
Description: CenteringPregnancy with Mindfulness Skills contains the CenteringPregnancy (CP) content combined with training in mindfulness meditation and mindful movement/yoga. The mind-body methods have been adapted from those taught in the Mindfulness-Based Childbirth and Parenting (MBCP) course, which is a tailored version of the Mindfulness-Based Stress Reduction program delivered to pregnant women during the perinatal period. These practices include mindfulness meditation of the breath, body, feelings, thoughts, and emotions; body scan meditation; yoga postures practiced with mindful awareness of the body and the physical changes associated with pregnancy; and loving-kindness meditation. In addition, MBCP includes specific exercises in coping with stress, pain, and fear associated with pregnancy, childbirth, and early parenting with a focus on shifting the way participants relate to negative thoughts and emotions and cope with stress.
Study NCT01969942 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: allogeneic stem cell transplantation
Study NCT01969942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clyclophosphamide
Study NCT01969942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabina
Study NCT01969942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Busulfan
Study NCT01969942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Study NCT04409652 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Head on bed
Description: During emergence, head is kept on bed without pillow.
Study NCT04409652 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Head on pillow
Description: During emergence, head is kept on pillow.
Study NCT01091909 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dental extractions
Description: All dental extractions were performed at an outpatient clinic at the USP Dental School. In addition, all extractions were performed under local anesthesia by the same experienced dentist, in accordance with the standards established by Peterson et al (2008).
Study NCT02500394 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ionosteril
Description: biomarker guided volume substitution with Ionosteril
Study NCT02500394 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Ionosteril
Description: biomarker guided volume substitution with Ionosteril
Study NCT03115112 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bexagliflozin
Description: tablets containing 20 mg bexagliflozin
Study NCT03115112 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sitagliptin
Description: tablets containing 100 mg sitagliptin
Study NCT03115112 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo for sitagliptin
Description: inactive tablets to match the appearance of sitagliptin tablets
Study NCT00494182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study NCT00494182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Given IV
Study NCT00494182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO
Study NCT04055753 — intervention group
Intervention type: DRUG
Intervention: Doxil
Description: Doxil 50 mg/m2, as per institutional standard
Study NCT01581788 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Divalproex Sodium
Description: Divalproex Sodium ER Tablets, 500 mg
Study NCT04407364 — intervention group
Intervention type: DEVICE
Intervention: CoMatryx Surgical Bovine Collagen
Description: The CoMatryx surgical collagen powder is a soft tissue repair product made of 100% type I bovine collagen
Study NCT04055753 — intervention group
Intervention type: DRUG
Intervention: Doxorubicin
Description: Doxorubicin 75 mg/m2, IV over 5-15 min OR Continuous infusion over 48-72 hours
Study NCT03115112 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo for bexagliflozin
Description: inactive tablets to match the appearance of bexagliflozin tablets
Study NCT01359644 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daclatasvir
Description: Tablets, oral, 60 mg, once daily
Study NCT01359644 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribavirin
Description: Tablets, oral, 200 mg
Study NCT02310646 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LEO 90100 Aerosol Foam
Description: Calcipotriol 50 mcg/g (as hydrate) and betamethasone 0.5 mg/g (as dipropionate) Aerosol Foam 60 g per can, applied once daily for one week
Study NCT02310646 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Daivobet® gel
Description: Calcipotriol 50 mcg/g (as hydrate) and betamethasone 0.5 mg/g (as dipropionate) Gel 60 g per bottle, applied once daily for one week.
Study NCT04775420 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of mean platelet volume (MPV) and blood neutrophil to lymphocyte ratio (NLR)
Description: MPV and NLR are easily accessible and inexpensive tests
Study NCT00931268 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Macrolane VRF 30
Description: One administration
Study NCT00608517 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-thymocyte globulin
Description: Given IV
Study NCT00608517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV
Study NCT00608517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fludarabine phosphate
Description: Given IV
Study NCT00608517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylprednisolone
Description: Given IV
Study NCT00608517 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: total-body irradiation
Description: Given daily for 1-4 days
Study NCT00203411 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine (Xeloda)
Description: 1000mg/m\^2 administered orally twice daily for two weeks followed by one week rest period
Study NCT04917497 — intervention group
Intervention type: DRUG
Intervention: Levosimendan
Description: Levosimendan was administered according to a standardized treatment protocol. A total dose of 12.5mg or 25mg (corresponding to one or two ampoules) was given at an infusion rate of 0.05 μg/kg/min to 0.2μg/kg/min with or without a loading dose (6 μg/kg or 3 μg/kg over 10 minutes). The decision about total dose, infusion rate and loading dose was at the discretion of the treating physician.
Study NCT04084340 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Real transcranial direct current stimulation + therapeutic exercises for urinary incontinence
Description: Real transcranial direct current stimulation associated with therapeutic exercises for urinary incontinence~tDCS: 20 minutes, 2mA, motor supplementary area anode and supraorbital cathode (ipsilateral to the dominant lower limb).Technique based on the application of weak, direct electrical current to the brain through relatively large electrodes that are placed over the scalp, in which anodal and cathodal stimulation increases and decreases cortical excitability, respectively.
Study NCT00203411 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 7.5 mg/kg IV will be administered every 3 weeks
Study NCT01925365 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: wholegrain cereals oats (WGO)
Description: Volunteers had to consume wholegrain cereals oats (WGO)(45g/day) for six weeks followed by a four week wash out period
Study NCT01925365 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Non wholegrain cereals
Description: Volunteers had to consume non wholegrain cereals (NWG)(45g/day) for six weeks followed by a four week wash out period.
Study NCT02044809 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol
Study NCT02044809 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03242148 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Toffee Nasal Pillows Mask
Description: Participants will be placed on this intervention for a total 14 ± 5 days from Visit 2. Participants will be using the Toffee nasal pillows mask during this treatment arm.
Study NCT04084340 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham transcranial direct current stimulation + therapeutic exercises for urinary incontinence
Description: Sham transcranial direct current stimulation + therapeutic exercises for urinary incontinence~tDCS: 20 minutes (30 seconds ON), 2mA, motor supplementary area anode and supraorbital cathode (ipsilateral to the dominant lower limb).Technique based on the application of weak, direct electrical current to the brain through relatively large electrodes that are placed over the scalp, in which anodal and cathodal stimulation increases and decreases cortical excitability, respectively.
Study NCT04091334 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Focused ultrasound of the lungs (FLUS) and focused cardiac ultrasound (FoCUS)
Description: FLUS: Scanning 8 zones of the front and lateral of the thorax. Record number of B-lines, consolidations, pneumothorax, pleural effusions.~FoCUS: Scan the heart in different views and record the ejection fraction, size of the right side of the heart, pericardial effusion, tricuspid annular plane systolic excursion (TAPSE), inferior vena cava (IVC) diameter, and IVC collapsibility Index (IVC-CI).
Study NCT04091334 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard care
Description: Standard care and evaluation and monitoring
Study NCT04091334 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: Standard care and evaluation and monitoring
Study NCT01923012 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin K2 (Menaquinone)
Study NCT00632424 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixabepilone (oral formulation)
Description: Capsules, Oral, Dose escalating (Phase 1), 3 doses on 1 day every 3 weeks, until disease progression or unacceptable toxicity
Study NCT03899532 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Conditioning
Description: Standard manual blood pressure cuff
Study NCT03899532 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: No-Remote Ischemic Conditioning
Description: No-Remote Ischemic Conditioning
Study NCT05396313 — intervention group
Intervention type: DEVICE
Intervention: CRT/ICD
Description: The patients received implantation of CRT/ICD.
Study NCT03903458 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tinostamustine
Description: First-in-human administration of the combination of Tinostamustine and Nivolumab.
Study NCT02537847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sitafloxacin
Description: The patients in intervention group will receive carbapenem for the first 3 days then sitafloxacin for 7 days. Total of treatment duration is 10 days.
Study NCT02537847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ertapenem
Description: Control group will be given ertapenem only for 10 days.
Study NCT00657228 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous heparin
Description: Intravenous heparin as an adjunct for the treatment of anaphylactic/anaphylactoid reactions in the Emergency Department.~To determine if a single bolus of intravenous unfractionated heparin (in conjunction with standard therapy) given to patients with anaphylactic/anaphylactoid reactions results in a faster time to recovery when compared to standard therapy alone.
Study NCT00657228 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Standard treatment (epinephrine, corticosteroids, diphenhydramine, and H2 blockers) and saline.
Study NCT00777127 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imiquimod
Description: One course of treatment (COT) consisting of an overnight application of IMIQ (1 sachet for up to 50 cm2), applied 3 nights per week (e.g. Monday, Wednesday, Friday) for 4 weeks followed by a 4 weeks treatment pause. If necessary, this may be followed by a second COT.
Study NCT00777127 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac
Description: Solaraze® is applied locally to the skin 2 times daily and smoothed into the skin gently. The amount needed depends on the size of the lesion. Normally 0.5 grams (the size of a pea) of the gel is used on a 25 cm2 lesion site. The duration of therapy is 12 weeks.
Study NCT02631018 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Weight Loss Intervention
Description: 18 session, group-based, 6-month, standard behavioral weight loss intervention
Study NCT02631018 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Enhanced Weight Loss Intervention
Description: 18 session, group-based, 6-month, physical activity enhanced behavioral weight loss intervention
Study NCT01192984 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KW-0761
Description: Intravenously 8 times at 1-week intervals
Study NCT01610076 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Code Status Video
Description: 10 minute video about Code Status
Study NCT01729572 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tele-medicine monitoring of medication adherence
Study NCT01016548 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AS03-adjuvanted H1N1 pandemic influenza vaccine
Description: One dose constitutes 0.5mL of suspended vaccine via the intramuscular route.
Study NCT01016548 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted H1N1 pandemic influenza vaccine
Description: One dose constitutes 0.5mL of suspended vaccine via the intramuscular route.
Study NCT02682030 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High Frequency Chest Compression Device (HFCC)
Description: A vest designed to help clear the airway of mucus and other secretions through mechanical knocking of the chest area.
Study NCT01339234 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Body-weight supported treadmill training
Description: Patients will undergo training using the Woodway Loco-system which consists of a treadmill with an overhead pulley system connected to a support harness. BWSTT allows patients with limited mobility to safely walk upright on a treadmill with a portion of their body weight counter balanced. Three trainers will be required to assist with the BWSTT program. Two trainers will be positioned at the lower limbs to manually guide the participant through a proper gait motion and provided lower limb control. A third trainer will stand behind the participant to provide trunk support and assist with weight shifting.
Study NCT02201043 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thalidomide 150mg
Study NCT02201043 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thalidomide 100mg
Study NCT02201043 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04527822 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse led discharge planning program
Description: a discharge planning program. It is a modified discharge planning program depends basically on the Re-Engineered Discharge program which is a program developed by Boston Medical Center in collaboration with AHRQ , 2013. The intervention consists of several components. The program components include making appointments for follow-up care (e.g., medical appointments and post discharge tests/labs). Plan for the follow-up of results from tests or labs that are pending at discharge. Identify the correct medicines and a plan for the patient to obtain them. Teach a written discharge plan the patient can understand. Educate the patient about his or her diagnosis and medicines. Review with the patient what to do if a problem arises. Assess the degree of the patient's understanding of the discharge plan and provide a telephone reinforcement of the discharge plan
Study NCT04527822 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nurse led discharge planning program
Description: a discharge planning program. It is a modified discharge planning program depends basically on the Re-Engineered Discharge program which is a program developed by Boston Medical Center in collaboration with AHRQ , 2013. The intervention consists of several components. The program components include making appointments for follow-up care (e.g., medical appointments and post discharge tests/labs). Plan for the follow-up of results from tests or labs that are pending at discharge. Identify the correct medicines and a plan for the patient to obtain them. Teach a written discharge plan the patient can understand. Educate the patient about his or her diagnosis and medicines. Review with the patient what to do if a problem arises. Assess the degree of the patient's understanding of the discharge plan and provide a telephone reinforcement of the discharge plan
Study NCT00214240 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CMV Immune globulin
Description: CMV IvIg 150mg/kg x 6 doses
Study NCT04425668 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Academic detailing (AD)
Description: In addition to continuing educational (CE) videos this group will receive up to two personalized, one-on-one, education sessions from an academic detailer. The sessions will last between 15-30 minutes. Each AD visit will consist of: an introduction, a brief needs assessment, key educational messages, a discussion of challenges the provider faces, and giving the provider leave-behind educational materials. The AD visit key educational messages are specific recommendations for opioid-prescribing practice change. When appropriate the detailer will suggest a phone call with Dr. Romesh Nalliah to discuss specific dentistry questions. There may also be a second AD visit if agreed upon by the dentist.
Study NCT02682030 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cough Assist
Description: A device that aids patients to clear mucus and secretions that they would otherwise be unable to clear with coughing.
Study NCT01816815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY1002670
Study NCT04180995 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TORIPALIMAB INJECTION(JS001 ) Axitinib tablet (Inlyta®)
Description: TORIPALIMAB INJECTION(JS001 ) combined with chemotherapy, 3mg/kg, Q2W,up to 1 years of treatment.
Study NCT04090437 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Catheter ablation procedure
Description: Catheter ablation procedure using Acutus mapping system
Study NCT02618343 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IPA
Description: IPA Aromatherapy for the experimental arm
Study NCT02618343 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ondansetron
Description: Zofran will be administered to the Control arm. This is the drug historically administered by prehospital personnel.
Study NCT04284280 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Routine vs Selective use of Human Milk Donor Fortifier
Description: Infants will be randomized to two groups. Both groups will be fed Premature Human Milk (either Maternal own milk or Premature donor human milk). However, one group will get fortified with Donor Human Milk Fortifier once full feed is reached while the second group will get fortified using the same fortifier only when weight gain is suboptimal.